ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

DCPC Board Approves “Working” Guidelines For Early Detection

October 2, 1987

CCOP Reviewers Briefed On Program Objective, Criteria

January 7, 1983

Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around

December 7, 1979

Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds

January 27, 2006

More Than 300 request RFP for New Community Oncology Program

May 25, 1979

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

March 12, 1999